{"id":"W1973588440","doi":"10.1007/s00280-013-2224-8","title":"A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Panobinostat; Medicine; Prostate cancer; Tolerability; Internal medicine; Oncology; Cancer; Clinical endpoint; Prostate-specific antigen; Phases of clinical research; Urology; Adverse effect; Chemotherapy; Clinical trial; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024118,0.001840829,0.002995853,0.0005779504,0.0006380889,0.0009822826,0.0008887809,0.001335303,0.004304676],"category_scores_gemma":[0.000891856,0.000823711,0.00151424,0.0006668097,0.001271909,0.001070442,0.000372461,0.003705224,0.0008408116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008893891,"about_ca_system_score_gemma":0.002182412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002546172,"about_ca_topic_score_gemma":0.005583739,"domain_scores_codex":[0.9995283,0.0002126606,0.00001502462,0.00008133509,0.00002921715,0.0001335546],"domain_scores_gemma":[0.9992799,0.0001165296,0.00007934719,0.00007154291,0.00003644546,0.0004162268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7830135,0.1057867,0.004606451,0.0004266044,0.0007621811,0.0002804445,0.0002574382,0.002602824,0.03185482,0.0002740972,0.001921231,0.06821369],"study_design_scores_gemma":[0.4489005,0.5396211,0.006459803,0.00001426027,0.0003006128,0.0001579521,0.00007208582,0.0007532243,0.002105232,0.0001199839,0.001470581,0.00002469568],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937742,0.001071135,0.000519187,0.0004656106,0.0001380161,0.001712566,0.0008072598,0.00007072308,0.001441267],"genre_scores_gemma":[0.9878236,0.002001568,0.0017694,0.0008112958,0.0002695042,0.002115551,0.002156162,0.00005136709,0.003001511],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004304676,"threshold_uncertainty_score":0.0144006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008602750773293795,"score_gpt":0.3132406636134182,"score_spread":0.3046379128401244,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}